PROVETOP

Human CD229/SLAMF3 Protein

Catalog No: CD229-HF001

Species
Human
Expression System
HEK293
Tag
an mFc (IgG1)

Product overview

Recombinant Human CD229/SLAMF3 Protein is expressed in HEK293 cells with an mFc (IgG1) tag at the C-terminus. It contains amino acid residues Gly251-Asn452 (UniProt accession: Q9HBG7-1).

Product Details

Molecular Aliases
SLAMF3; CD229; LY9; AI893573; Lgp100; T100
Protein Length
Gly251-Asn452
Expression System
HEK293
Theoretical Molecular Weight
The protein has a predicted MW of 48.04 kDa. Due to glycosylation, the protein migrates to 55-70 kDa based on Bis-Tris PAGE result.
Purity
> 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC
Endotoxin
Less than 1 EU per μg by the LAL method.
Buffer / Formulation
Supplied as 0.22 μm filtered solution in PBS (pH 7.4).
State
Liquid
Storage Conditions
Valid for 12 months from date of receipt when stored at -80°C. Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.

Data Display

Bis-Tris PAGE
CD229-HF001 Bis-Tris-PAGE-white result

Human CD229 on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

SEC-HPLC
CD229-HF001 SEC-HPLC result

The purity of Human CD229 is greater than 95% as determined by SEC-HPLC.

Background

CD229 was strongly and homogeneously overexpressed on the PC of patients with monoclonal gammopathy of undetermined significance (MGUS), smoldering myeloma, MM, and PC leukemia. CD229 was particularly overexpressed on those PC showing an abnormal phenotype such as expression of CD56. Most importantly, CD229 was also highly expressed on those cells in the patients' BM displaying the phenotype of chemotherapy-resistant and myeloma-propagating cells.

References

  1. Yousef S, Kovacsovics-Bankowski M, Salama ME, Bhardwaj N, Steinbach M, Langemo A, Kovacsovics T, Marvin J, Binder M, Panse J, Kröger N, Luetkens T, Atanackovic D. CD229 is expressed on the surface of plasma cells carrying an aberrant phenotype and chemotherapy-resistant precursor cells in multiple myeloma. Hum Vaccin Immunother. 2015;11(7):1606-11. doi: 10.1080/21645515.2015.1046658. PMID: 26001047; PMCID: PMC4514151.

Have questions about this product?

Our technical team can help with product selection, application questions and order support.

Contact Technical Support